Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Presence of...

    Presence of Formaldehyde in JnJ baby shampoo; company junks Rajasthan report

    Meghna A SinghaniaWritten by Meghna A Singhania Published On 2019-04-29T10:00:37+05:30  |  Updated On 29 April 2019 10:00 AM IST
    Presence of Formaldehyde in JnJ baby shampoo; company junks Rajasthan report

    Based on the report of the Drug Testing Laboratory in Jaipur, the National Commission for Protection of Child Rights (NCPCR) has written to the chief secretaries of all states and Union Territories asking them to stop the sale of Johnson & Johnson's (JnJ) baby shampoo and remove it from the stocks.


    New Delhi: Johnson & Johnson has strongly rejected findings of a Rajasthan government laboratory showing the presence of "harmful" chemicals in the US-based company's baby shampoo, a popular product in India.


    Based on the report of the Drug Testing Laboratory in Jaipur, the National Commission for Protection of Child Rights (NCPCR) has written to the chief secretaries of all states and Union Territories asking them to stop the sale of Johnson & Johnson's (JnJ) baby shampoo and remove it from the stocks.


    The NCPCR said the test report found the presence of formaldehyde in J&J's baby shampoo.


    The company, in a statement, said it has not received any direction to stop the sale of its shampoo and that it was not accepting the interim results of the laboratory tests which were based on "unknown and unspecified" methods.


    India is a major market for J&J globally, and its share in the country's Rs 4,000-crore baby care market is nearly three-fourths.


    "We will await the results and conclusions of the re-testing process at the Central Drugs Laboratory. We are not aware of any directions from NCPCR. It must be noted that any such directions, under the law, can only be issued under certain prescribed conditions," the company said.


    Read Also: Compensation formula: Delhi HC junks Johnson and Johnson’s plea


    J&J said it is in full compliance with current Indian regulatory requirements and standards for manufacturing and testing of all its products.


    "We have confirmed to the Indian authorities that we do not add Formaldehyde as an ingredient in our shampoo nor does Johnson's baby shampoo contain any ingredient that can release formaldehyde over time. Our products are safe to use and conform to all applicable standard under the D&C (Drugs and Cosmetics) Act and D&C rules," it said.


    "We unequivocally maintain that our products are safe, and our assurance process is amongst the most rigorous in the world, meeting or exceeding the safety standards in every country where our products are sold," the company added.


    Also Read: MORE TEARS: After Talcum Powder, JnJ Baby Shampoo reveals the presence of Carcinogens


    Officials said NCPCR has powers to recommend action, but it was for the state governments and union territories to take a call on the implementation of the recommendation by the apex child rights body.


    The NCPCR had sought sample test reports of J&J's baby shampoo and talcum powder from authorities of five states -- Andhra Pradesh (south), Jharkhand (east), Rajasthan (west), Madhya Pradesh (central) and Assam (North East) -- after reports of presence of asbestos and carcinogenic substance in them emerged.


    The order by the NCPCR around a week back was issued after test reports of the baby shampoo came from Rajasthan. However, it is yet to receive test reports from the other four states.


    The NCPCR has asked the Drug Control Officer of Rajasthan to send the test report of the talcum powder at the earliest, officials at the child rights body said.


    In December last year, India's drug regulator ordered laboratory testing of J&J's baby powder following international media reports it may contain cancer-causing asbestos. Months later, test reports showed that the talcum powder did not contain asbestos.

    Central Drugs LaboratoryDrug Testing Laboratory JaipurDrugs and Cosmetics ActformaldehydeJ&J baby powderJ&J baby shampooJnJJnJ baby shampooJnJ shampooJohnson and JohnsonNational Commission for Protection of Child RightsNCPCRNew DelhiRajasthan government laboratoryRajasthan JnJrigorous
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Meghna A Singhania
    Meghna A Singhania

      Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok